First Page | Document Content | |
---|---|---|
Date: 2015-06-26 19:54:25 | Important Safety Information for Infectious Disease Specialists About Potential Risks of Infections With ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the FoodAdd to Reading ListSource URL: www.actemrahcp.comDownload Document from Source WebsiteFile Size: 892,99 KBShare Document on Facebook |